These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 26436831)

  • 21. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital.
    Zhao ZC; Xu XH; Liu MB; Wu J; Lin J; Li B
    Am J Infect Control; 2014 May; 42(5):e61-4. PubMed ID: 24773806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
    Chea N; Bulens SN; Kongphet-Tran T; Lynfield R; Shaw KM; Vagnone PS; Kainer MA; Muleta DB; Wilson L; Vaeth E; Dumyati G; Concannon C; Phipps EC; Culbreath K; Janelle SJ; Bamberg WM; Guh AY; Limbago B; Kallen AJ
    Emerg Infect Dis; 2015 Sep; 21(9):1611-6. PubMed ID: 26290955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
    Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):183-6. PubMed ID: 26164275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thirty-day laboratory-based surveillance for carbapenem-resistant Enterobacteriaceae in the Minneapolis-St. Paul metropolitan area.
    Pereira EC; Shaw KM; Vagnone PM; Harper JE; Kallen AJ; Limbago BM; Lynfield R
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):423-5. PubMed ID: 24602949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
    Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
    Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
    Satlin MJ; Calfee DP; Chen L; Fauntleroy KA; Wilson SJ; Jenkins SG; Feldman EJ; Roboz GJ; Shore TB; Helfgott DC; Soave R; Kreiswirth BN; Walsh TJ
    Leuk Lymphoma; 2013 Apr; 54(4):799-806. PubMed ID: 22916826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
    Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
    J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.
    Thaden JT; Lewis SS; Hazen KC; Huslage K; Fowler VG; Moehring RW; Chen LF; Jones CD; Moore ZS; Sexton DJ; Anderson DJ
    Infect Control Hosp Epidemiol; 2014 Aug; 35(8):978-83. PubMed ID: 25026612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae.
    He Q; Chen W; Huang L; Lin Q; Zhang J; Liu R; Li B
    Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):40. PubMed ID: 27328762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Molecular and Phenotypic Methods for the Detection and Characterization of Carbapenem Resistant Enterobacteriaceae.
    Somily AM; Garaween GA; Abukhalid N; Absar MM; Senok AC
    Acta Microbiol Immunol Hung; 2016 Mar; 63(1):69-81. PubMed ID: 27020870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
    Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
    PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case-control-control study.
    Torres-González P; Ortiz-Brizuela E; Cervera-Hernandez ME; Bobadilla-Del Valle M; Martínez-Gamboa A; Sifuentes-Osornio J; Ponce-de-Leon A
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):243-8. PubMed ID: 27519297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
    Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015.
    Bulens SN; Reses HE; Ansari UA; Grass JE; Carmon C; Albrecht V; Lawsin A; McAllister G; Daniels J; Lee YK; Yi S; See I; Jacob JT; Bower CW; Wilson L; Vaeth E; Lynfield R; Vagnone PS; Shaw KM; Dumyati G; Tsay R; Phipps EC; Bamberg W; Janelle SJ; Beldavs ZG; Cassidy PM; Kainer M; Muleta D; Mounsey JT; Laufer-Halpin A; Karlsson M; Lutgring JD; Walters MS
    Am J Infect Control; 2023 Jan; 51(1):70-77. PubMed ID: 35909003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.
    Drew RJ; Turton JF; Hill RL; Livermore DM; Woodford N; Paulus S; Cunliffe NA
    J Hosp Infect; 2013 Aug; 84(4):300-4. PubMed ID: 23831281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.
    Guh AY; Limbago BM; Kallen AJ
    Expert Rev Anti Infect Ther; 2014 May; 12(5):565-80. PubMed ID: 24666262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.